Study
UC-II May Improve Knee Osteoarthritis Symptoms in Seniors
A study found that UC-II, a collagen supplement, reduced knee osteoarthritis pain and improved function in seniors more effectively than glucosamine and chondroitin.
Summary
In plain language
If you're experiencing knee pain due to osteoarthritis, there's a new supplement that might help. A recent study looked at UC-II, a type of collagen from chicken cartilage, to see if it could ease symptoms of knee osteoarthritis in seniors. The results were promising: after 90 days, those taking UC-II reported a 33% improvement in pain and function, compared to only 14% improvement in those taking glucosamine and chondroitin. This could mean less pain and easier movement for those struggling with this common joint issue. As always, it’s best to talk to your healthcare provider before starting any new supplement.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study explored the effects of UC-II, a collagen supplement, on knee osteoarthritis in older adults. Participants were divided into two groups: one taking UC-II and the other taking glucosamine and chondroitin.
The study was a controlled trial with 52 participants, assessing pain and function over 90 days using standardized scores.
UC-II showed a 33% reduction in pain and improved function, significantly more than the 14% improvement seen in the glucosamine and chondroitin group.
No significant side effects were reported, making UC-II a potentially safer alternative to traditional medications.
Consider discussing UC-II with your healthcare provider to see if it might be a good option for managing your osteoarthritis symptoms.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
UC-II May Improve Knee Osteoarthritis Symptoms in Seniors
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored highly due to its robust RCT design with confirmed randomization, blinding, and allocation concealment. Statistical methods were appropriate, but transparency was limited by the lack of pre-registration and data sharing. The study is directly relevant to the target population of older adults. However, no replication evidence was provided, and journal quality could not be assessed.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This randomized controlled trial evaluated the efficacy of UC-II versus glucosamine and chondroitin in treating knee osteoarthritis in older adults. UC-II showed greater improvement in WOMAC, VAS, and Lequesne scores over 90 days.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.